#USA #Burlington #OSOM®RSV #SEKISUI Diagnostics #Rapid Test

SEKISUI Diagnostics Unveils OSOM® RSV Test

SEKISUI Diagnostics, a leading player in the global medical diagnostics sector, has recently launched an innovative rapid diagnostic tool aimed at improving the detection of Respiratory Syncytial Virus (RSV). The OSOM® RSV Test provides healthcare professionals with a swift and reliable way to diagnose RSV infections in at-risk populations.

Key Features of the OSOM® RSV Test

The OSOM® RSV Test employs a rapid immunochromatographic assay that can effectively detect the RSV nucleoprotein antigen from nasal swabs. Remarkably, results can be obtained in just 15 minutes, making it an ideal option for clinical settings needing quick patient evaluations. Notably, the test is CLIA-waived for point-of-care usage, facilitating broader accessibility for healthcare providers. While many rapid tests exist, what sets the OSOM® RSV Test apart is its target demographic that includes children aged 6 months to 6 years and adults over 60, a demographic that is especially vulnerable to severe RSV infection.

Importance of Accurate and Timely Diagnoses

Harold Chan, the Vice President and General Manager of the Point-of-Care Business Unit at SEKISUI Diagnostics, emphasized the importance of accurate diagnostics in treating respiratory infections. Due to the commonality of symptoms among various respiratory illnesses, having a precise and prompt test like the OSOM® RSV Test is crucial. It allows for better patient management and timely interventions, especially with newer treatments becoming available in the market.

Unique Quality Control Features

One of the notable advantages of this new product includes the QC Inside® feature, which offers two additional tests per kit for external quality control testing at no extra charge. This helps healthcare providers maintain laboratory standards while also being financially beneficial for their practices. David Morris, Associate Director of Product Management at SEKISUI Diagnostics, pointed out that this feature not only enhances operational protocols but also optimizes cost efficiency for healthcare providers.

About SEKISUI Diagnostics

SEKISUI Diagnostics has a stellar reputation built over 40 years in delivering effective medical diagnostic solutions. The company is committed to leveraging science to improve overall health outcomes. Their extensive product range includes clinical chemistry reagents, point-of-care tests, and specialty biochemicals, serving healthcare professionals, laboratories, and testing locations around the world. With its robust portfolio, including brands such as OSOM®, Metrix®, and Acucy®, SEKISUI is dedicated to enhancing health diagnostics globally by providing intelligent, science-backed solutions.

In conclusion, the launch of the OSOM® RSV Test by SEKISUI Diagnostics marks a significant advancement in respiratory diagnostics, particularly given the escalating need for rapid and accurate testing tools amidst ongoing health challenges. The integration of innovative features catered to high-risk demographics promises to enhance the ability of medical personnel to diagnose and treat RSV effectively.

For more information about SEKISUI Diagnostics and their innovative products, please visit their official website.